作者:Hendra Gunosewoyo、Jun Liu Guo、Maxwell R. Bennett、Mark J. Coster、Michael Kassiou
DOI:10.1016/j.bmcl.2008.05.062
日期:2008.7
Polycyclic amides 2 and 5-9 were successfully synthesised and their lipophilicity profiles were evaluated using reverse-phase HPLC. All synthesised compounds possessed P2X7R antagonistic properties when tested on rat spinal cord microglia cells. Extensive screening for binding to other neuroreceptor subtypes demonstrated their P2X7 selectivity.
4-Substituted Cubylcarbinylamines: A New Class of Mechanism-Based Monoamine Oxidase B Inactivators
作者:Joseph J. P. Zhou、Jianchang Li、Suhbash Upadhyaya、Philip E. Eaton、Richard B. Silverman
DOI:10.1021/jm9606249
日期:1997.3.1
time-dependent, irreversible inactivators of monoamine oxidase B (MAO B). Substrate protects the enzyme from inactivation, but beta-mercaptoethanol does not, suggesting that these compounds are mechanism-based inactivators. All three compounds were also substrates for MAO B with partition ratios ranging from 152 to 536. The 4-substituted analogues were more potentinactivators than the unsubstituted analogue
The First CNS-Active Carborane: A Novel P2X<sub>7</sub> Receptor Antagonist with Antidepressant Activity
作者:Shane M. Wilkinson、Hendra Gunosewoyo、Melissa L. Barron、Aurelie Boucher、Michelle McDonnell、Peter Turner、Daniel E. Morrison、Maxwell R. Bennett、Iain S. McGregor、Louis M. Rendina、Michael Kassiou
DOI:10.1021/cn500054n
日期:2014.5.21
Relative to other polycyclic frameworks (1-3), a carborane cage (4 and Cs center dot 5) exerts a significant biological effect as an inhibitor of the purinergic P2X(7) receptor (P2X(7)R) which allows one to target depression in vivo and thus demonstrate, for the first time, that a carborane has the capacity to modify CNS activity.[GRAPHICS]
Structure–activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptors
作者:Corinne Beinat、Samuel D. Banister、Jane Hoban、John Tsanaktsidis、Athanasios Metaxas、Albert D. Windhorst、Michael Kassiou
DOI:10.1016/j.bmcl.2013.12.087
日期:2014.2
GluN2B subtype-selective NMDA antagonists represent promising therapeutic targets for the symptomatic treatment of multiple CNS pathologies. A series of N-benzyl substituted benzamidines were synthesised and the benzyl ring was further replaced with various polycyclic moieties. Compounds were evaluated for activity at GluN2B containing NMDA receptors where analogues 9, 12, 16 and 18 were the most potent of the series, replacement of the benzyl ring with polycycles resulted in a complete loss of activity. (C) 2013 Elsevier Ltd. All rights reserved.